Financials

Discussions Technicals Seasonals

251280 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

AngioLab, Inc. engages in the development, manufacture, and distribution of pharmaceutical products. Its products include medicines for ophthalmic disorders, periodontal diseases, anti-obesity drugs, anti-inflammation treatments, and psoriasis cares, health functional foods for internal organ fat controls, and cosmetics for anti-wrinkle. The company was founded by Kim Min-Yeong on June 3, 1999 and is headquartered in Daejeon, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

251280 does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company